Literature DB >> 11476445

Competitive polymerase chain reaction used to diagnose cutaneous leishmaniasis in German soldiers infected during military exercises in French Guiana.

G Bezold1, M Lange, K Gethöffer, H Pillekamp, H Reindl, C Richter, G Schönian, L Weber, R U Peter.   

Abstract

A competitive polymerase chain reaction (PCR) followed by enzyme-linked-immunoassay-based verification of PCR products has been developed, which facilitated the diagnosis of leishmaniasis in two German soldiers who underwent survival training in the jungle of French Guiana and returned with therapy-resistant pyoderma-like lesions. After treatment with liposomal amphotericin B, the skin manifestations disappeared, and leishmania DNA could no longer be detected by PCR. In the context of growing military involvement in areas where leishmaniasis is prevalent, this assay may help detect or, due to its internal controls, exclude cases of infection with this parasite.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476445     DOI: 10.1007/s100960100519

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

1.  Evaluation of PCR as a diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic dogs (Canis familiaris).

Authors:  Richard Reithinger; Juan Canales Espinoza; Orin Courtenay; Clive R Davies
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Diagnosis and identification of Leishmania spp. from Giemsa-stained slides, by real-time PCR and melting curve analysis in south-west of Iran.

Authors:  S Khademvatan; N Neisi; S Maraghi; J Saki
Journal:  Ann Trop Med Parasitol       Date:  2011-12

3.  [Cutaneous leishmaniasis--an import from Belize].

Authors:  Jakob Schnedl; Herbert Auer; Marcellus Fischer; Herbert Tomaso; Tom Pustelnik; Gerhard Mooseder
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis.

Authors:  Jutta Marfurt; Abed Nasereddin; Igor Niederwieser; Charles L Jaffe; Hans-Peter Beck; Ingrid Felger
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.